Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA War On Tainted Supplements Wages On

This article was originally published in The Tan Sheet

Executive Summary

A warning letter about tainted dietary supplements is a reminder that even though recalls of spiked supplements are declining, products marketed as supplements that contain undeclared prescription drugs still infiltrate the market. The letter illustrates recalling tainted supplements may not prevent future enforcement actions.


Related Content

In Brief
FDA Signals Progress In War On Adulterated Supplements
FDA, Trade Groups Team Up To Bolster Enforcement On Tainted Supplements
One-Third Of Supplement GMP Inspections Reveal "Serious Problems" - FDA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts